RY

Rashmi Yadav

Active Director Director DIN 09657096
DIN 09657096 First appointment Jun 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value •••• Premium profile

About Rashmi Yadav

Data last updated:

Rashmi Yadav is a Director at Bioepic Laboratory Private Limited (since 2022). The company operates in Trading. Bioepic Laboratory Private Limited reported revenue of ₹37,890 (FY 2025).

DIN 09657096
Primary Designation Director
Industry Trading
First Appointment 29 Jun 2022
Oldest Company Age 4 yrs
Largest company Bioepic Laboratory Private Limited · ₹37,890 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bioepic Laboratory Private Limited U51909UP2022PTC166744
Director29 Jun 20222022₹37,890 (FY 2025)Active

Board colleagues of Rashmi Yadav

Directorship timeline

Open interactive timeline →
Bioepic Laboratory Private Limited
Premium access

Shareholding and investment profile for Rashmi Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rashmi Yadav

Rashmi Yadav currently holds 1 directorship: Bioepic Laboratory Private Limited (Director, since 29 Jun 2022, revenue ₹37,890 (FY 2025)).

Rashmi Yadav was first appointed on 29 Jun 2022 as Director at Bioepic Laboratory Private Limited.

The current boards of Rashmi Yadav's companies include Krishna Kant Tyagi (Bioepic Laboratory Private Limited), Krishna Kumar Shukla (Bioepic Laboratory Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available